Delivery Order SPE2DR25D1053-SPE2DR26FT617
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,087.04 to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Lisdexamfetamine 70 mg capsules (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,850.60 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 60 mg capsules (90-count units). The contract was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, using firm fixed pricing with no set-aside designation. Performance will be conducted at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award issued...
- The Defense Logistics Agency awarded a delivery order contract valued at $2,586.18 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 70 mg capsules in quantities of 100 units. This competitive, non-set-aside award with firm fixed pricing was issued on October 24, 2025, with an ultimate completion date of October 27, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,897.96 for Lisdexamfetamine 70 mg capsules (100-count units) on September 26, 2025, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued under the company's existing Indefinite...
- The Defense Logistics Agency awarded a $2,898.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Lisdexamfetamine 50 mg capsules (90-count units). The contract, which is a non-set-aside award, is scheduled for completion on October 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency has awarded a delivery order valued at $2,046.85 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 20 mg capsules (100 count). This firm fixed-price delivery order, issued on April 25, 2025, with an ultimate completion date of April 28, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The...
- The Defense Logistics Agency awarded a delivery order valued at $5,095.36 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 20 mg capsules (100 count) on October 29, 2025, with an ultimate completion date of October 30, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100-count units) under a firm fixed-price contract valued at $2,646.20. The contract was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,768.95 for 90 capsules of Lisdexamfetamine 60 mg on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a $2,681.36 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Lisdexamfetamine 50 mg capsules (90-count units). This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The delivery order is scheduled for...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT617Delivery Order
The Defense Logistics Agency has awarded a delivery order valued at $4,143.96 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 50 mg capsules (100 count). This competitively awarded, firm fixed-price contract was issued on November 5, 2025, with an ultimate completion date of November 6, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio with the Defense Logistics Agency encompasses a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for lisdexamfetamine, a medication commonly used in the treatment of attention deficit hyperactivity disorder, exemplifies the company's role in supplying essential medications to support Defense Health Agency operations and other federal healthcare systems through its flexible and comprehensive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 11/5/25 |